Primary vascularization of allografts governs their immunogenicity and susceptibility to tolerogenesis

Journal of Immunology

Volumn 191, Issue 4, 2013, Pages 1948-1956

  Kant, Cavit D ^a   Akiyama, Yoshinobu ^a   Tanaka, Katsunori ^a   Shea, Susan ^a   Connolly, Sarah E ^a   Germana, Sharon ^a   Winn, Henry J ^a   LeGuern, Christian ^a   Tocco, Georges ^a   Benichou, Gilles ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD40 LIGAND ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ALLOGRAFT; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; KIDNEY TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN ALLOGRAFT; SKIN GRAFT; SKIN TRANSPLANTATION; T LYMPHOCYTE; VASCULARIZATION;

ALLOGRAFTS; ANASTOMOSIS, SURGICAL; ANIMALS; ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; ORGAN SPECIFICITY; SKIN; SKIN TRANSPLANTATION; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE; TRANSPLANTS;

EID: 84881468531     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202092     Document Type: Article

References (56)

1. Lechler, R. I., G. Lombardi, J. R. Batchelor, N. Reinsmoen, and F. H. Bach. 1990. The molecular basis of alloreactivity. Immunol. Today 11: 83-88.
2. Benichou, G., P. A. Takizawa, C. A. Olson, M. McMillan, and E. E. Sercarz. 1992. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J. Exp. Med. 175: 305-308.
3. Benichou, G., A. Valujskikh, and P. S. Heeger. 1999. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J. Immunol. 162: 352-358.
4. Auchincloss, H., Jr., R. Lee, S. Shea, J. S. Markowitz, M. J. Grusby, and L. H. Glimcher. 1993. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc. Natl. Acad. Sci. USA 90: 3373-3377.
5. Illigens, B. M., A. Yamada, N. Anosova, V. M. Dong, M. H. Sayegh, and G. Benichou. 2009. Dual effects of the alloresponse by Th1 and Th2 cells on acute and chronic rejection of allotransplants. Eur. J. Immunol. 39: 3000-3009.
6. Russell, P. S., C. M. Chase, and R. B. Colvin. 1997. Alloantibody- and T cellmediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice. Transplantation 64: 1531-1536.
7. Suciu-Foca, N., Z. Liu, P. E. Harris, E. F. Reed, D. J. Cohen, J. A. Benstein, A. I. Benvenisty, D. Mancini, R. E. Michler, E. A. Rose, et al. 1995. Indirect recognition of native HLA alloantigens and B-cell help. Transplant. Proc. 27: 455-456.
8. Lee, R. S., K. Yamada, S. L. Houser, K. L. Womer, M. E. Maloney, H. S. Rose, M. H. Sayegh, and J. C. Madsen. 2001. Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy. Proc. Natl. Acad. Sci. USA 98: 3276-3281.
9. Lakkis, F. G., B. T. Konieczny, S. Saleem, F. K. Baddoura, P. S. Linsley, D. Z. Alexander, R. P. Lowry, T. C. Pearson, and C. P. Larsen. 1997. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4. J. Immunol. 158: 2443-2448.
10. Larsen, C. P., and T. C. Pearson. 1997. The CD40 pathway in allograft rejection, acceptance, and tolerance. Curr. Opin. Immunol. 9: 641-647.
11. Sykes, M., G. L. Szot, K. A. Swenson, and D. A. Pearson. 1997. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat. Med. 3: 783-787.
12. Kawai, T., A. B. Cosimi, T. R. Spitzer, N. Tolkoff-Rubin, M. Suthanthiran, S. L. Saidman, J. Shaffer, F. I. Preffer, R. Ding, V. Sharma, et al. 2008. HLAmismatched renal transplantation without maintenance immunosuppression. N. Engl. J. Med. 358: 353-361.
13. Steinmuller, D. 2001. Skin allograft rejection by stable hematopoietic chimeras that accept organ allografts sill is an enigma. Transplantation 72: 8-9.
14. Merad, M., P. Hoffmann, E. Ranheim, S. Slaymaker, M. G. Manz, S. A. Lira, I. Charo, D. N. Cook, I. L. Weissman, S. Strober, and E. G. Engleman. 2004. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat. Med. 10: 510-517.
15. Larsen, C. P., R. M. Steinman, M. Witmer-Pack, D. F. Hankins, P. J. Morris, and J. M. Austyn. 1990. Migration and maturation of Langerhans cells in skin transplants and explants. J. Exp. Med. 172: 1483-1493.
16. Ginhoux, F., M. P. Collin, M. Bogunovic, M. Abel, M. Leboeuf, J. Helft, J. Ochando, A. Kissenpfennig, B. Malissen, M. Grisotto, et al. 2007. Bloodderived dermal langerin+ dendritic cells survey the skin in the steady state. J. Exp. Med. 204: 3133-3146.
17. Billingham, R. E., and P. D. Medawar. 1951. The technique of free skin grafting in mammals. J. Exp. Biol. 28: 385-402.
18. Larsen, C. P., E. T. Elwood, D. Z. Alexander, S. C. Ritchie, R. Hendrix, C. Tucker-Burden, H. R. Cho, A. Aruffo, D. Hollenbaugh, P. S. Linsley, et al. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381: 434-438.
19. LeGuern, C., Y. Akiyama, S. Germana, K. Tanaka, L. Fernandez, Y. Iwamoto, S. Houser, and G. Benichou. 2010. Intracellular MHC class II controls regulatory tolerance to allogeneic transplants. J. Immunol. 184: 2394-2400.
20. Bingaman, A. W., J. Ha, M. M. Durham, S. Y. Waitze, C. Tucker-Burden, S. R. Cowan, T. C. Pearson, and C. P. Larsen. 2001. Analysis of the CD40 and CD28 pathways on alloimmune responses by CD4+ T cells in vivo. Transplantation 72: 1286-1292.
21. Larsen, C. P., D. Z. Alexander, D. Hollenbaugh, E. T. Elwood, S. C. Ritchie, A. Aruffo, R. Hendrix, and T. C. Pearson. 1996. CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 61: 4-9.
22. Kishimoto, K., V. M. Dong, S. Issazadeh, E. V. Fedoseyeva, A. M. Waaga, A. Yamada, M. Sho, G. Benichou, H. Auchincloss, Jr., M. J. Grusby, et al. 2000. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. J. Clin. Invest. 106: 63-72.
23. Sayegh, M. H., E. Akalin, W. W. Hancock, M. E. Russell, C. B. Carpenter, P. S. Linsley, and L. A. Turka. 1995. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181: 1869-1874.
24. Cobbold, S. P., E. Adams, L. Graca, S. Daley, S. Yates, A. Paterson, N. J. Robertson, K. F. Nolan, P. J. Fairchild, and H. Waldmann. 2006. Immune privilege induced by regulatory T cells in transplantation tolerance. Immunol. Rev. 213: 239-255.
25. Torrealba, J. R., M. Katayama, J. H. Fechner, Jr., E. Jankowska-Gan, S. Kusaka, Q. Xu, J. M. Schultz, T. D. Oberley, H. Hu, M. M. Hamawy, et al. 2004. Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates. J. Immunol. 172: 5753-5764.
26. Salama, A. D., N. Najafian, M. R. Clarkson, W. E. Harmon, and M. H. Sayegh. 2003. Regulatory CD25+ T cells in human kidney transplant recipients. J. Am. Soc. Nephrol. 14: 1643-1651.
27. Bluestone, J. A., and Q. Tang. 2004. Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells. Proc. Natl. Acad. Sci. U S A. 101 (Suppl. 2): 14622-14626.
28. Perloff, L. J., and C. F. Barker. 1980. Studies of the immediately vascularized skin allograft. Br. J. Surg. 67: 289-293.
29. Iwata, T., Y. Kamei, S. Esaki, T. Takada, S. Torii, A. Yamashita, S. Tomida, T. Tamatani, M. Miyasaka, and Y. Yoshikai. 1996. Immunosuppression by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies of free and vascularized skin allograft rejection. Immunobiology 195: 160-171.
30. Yamada, A., T. M. Laufer, A. J. Gerth, C. M. Chase, R. B. Colvin, P. S. Russell, M. H. Sayegh, and H. Auchincloss, Jr. 2003. Further analysis of the T-cell subsets and pathways of murine cardiac allograft rejection. Am. J. Transplant. 3: 23-27.
31. Pietra, B. A., A. Wiseman, A. Bolwerk, M. Rizeq, and R. G. Gill. 2000. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J. Clin. Invest. 106: 1003-1010.
32. Fangmann, J., R. Dalchau, and J. W. Fabre. 1992. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J. Exp. Med. 175: 1521-1529.
33. Weiss, M. J., D. A. Guenther, J. D. Mezrich, H. Sahara, C. Y. Ng, A. J. Meltzer, J. K. Sayre, M. E. Cochrane, A. C. Pujara, S. L. Houser, et al. 2009. The indirect alloresponse impairs the induction but not maintenance of tolerance to MHC class I-disparate allografts. Am. J. Transplant. 9: 105-113.
34. Brennan, T. V., A. Jaigirdar, V. Hoang, T. Hayden, F. C. Liu, H. Zaid, C. K. Chang, R. P. Bucy, Q. Tang, and S. M. Kang. 2009. Preferential priming of alloreactive T cells with indirect reactivity. Am. J. Transplant. 9: 709-718.
35. Suciu-Foca, N., R. Ciubotariu, A. Colovai, A. Foca-Rodi, E. Ho, E. Rose, and R. Cortesini. 1999. Persistent allopeptide reactivity and epitope spreading in chronic rejection. Transplant. Proc. 31: 100-101.
36. Valujskikh, A., and P. S. Heeger. 2000. CD4+ T cells responsive through the indirect pathway can mediate skin graft rejection in the absence of interferongamma. Transplantation 69: 1016-1019.
37. Steinmuller, D. 1980. Passenger leukocytes and the immunogenicity of skin allografts. J. Invest. Dermatol. 75: 107-115.
38. Barker, C. F., and R. E. Billingham. 1968. The role of afferent lymphatics in the rejection of skin homografts. J. Exp. Med. 128: 197-221.
39. Lakkis, F. G., A. Arakelov, B. T. Konieczny, and Y. Inoue. 2000. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat. Med. 6: 686-688.
40. Austyn, J. M., and C. P. Larsen. 1990. Migration patterns of dendritic leukocytes. Implications for transplantation. Transplantation 49: 1-7.
41. Williams, M. A., J. Trambley, J. Ha, A. B. Adams, M. M. Durham, P. Rees, S. R. Cowan, T. C. Pearson, and C. P. Larsen. 2000. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts. J. Immunol. 165: 6849-6857.
42. Bushell, A., M. Karim, C. I. Kingsley, and K. J. Wood. 2003. Pretransplant blood transfusion without additional immunotherapy generates CD25+CD4+ regulatory T cells: a potential explanation for the blood-transfusion effect. Transplantation 76: 449-455.
43. Pearl, J. P., H. Xu, F. Leopardi, E. Preston, and A. D. Kirk. 2007. CD154 blockade, sirolimus, and donor-specific transfusion prevents renal allograft rejection in cynomolgus monkeys despite homeostatic T-cell activation. Transplantation 83: 1219-1225.
44. Chalermskulrat, W., K. P. McKinnon, W. J. Brickey, I. P. Neuringer, R. C. Park, D. G. Sterka, B. R. Long, P. McNeillie, R. J. Noelle, J. P. Ting, and R. M. Aris. 2006. Combined donor specific transfusion and anti-CD154 therapy achieves airway allograft tolerance. Thorax 61: 61-67.
45. Wise, M. P., F. Bemelman, S. P. Cobbold, and H. Waldmann. 1998. Linked suppression of skin graft rejection can operate through indirect recognition. J. Immunol. 161: 5813-5816.
46. Yamada, A., A. Chandraker, T. M. Laufer, A. J. Gerth, M. H. Sayegh, and H. Auchincloss, Jr. 2001. Recipient MHC class II expression is required to achieve long-term survival of murine cardiac allografts after costimulatory blockade. J. Immunol. 167: 5522-5526.
47. Horibe, E. K., J. Sacks, J. Unadkat, G. Raimondi, Z. Wang, R. Ikeguchi, D. Marsteller, L. M. Ferreira, A. W. Thomson, W. P. Lee, and M. Feili-Hariri. 2008. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion. Transpl. Immunol. 18: 307-318.
48. Faria, A. M., and H. L. Weiner. 2005. Oral tolerance. Immunol. Rev. 206: 232-259.
49. Liblau, R. S., R. Tisch, K. Shokat, X. Yang, N. Dumont, C. C. Goodnow, and H. O. McDevitt. 1996. Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis. Proc. Natl. Acad. Sci. USA 93: 3031-3036.
50. Thorstenson, K. M., and A. Khoruts. 2001. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167: 188-195.
51. Valujskikh, A., A. M. VanBuskirk, C. G. Orosz, and P. S. Heeger. 2001. A role for TGFbeta and B cells in immunologic tolerance after intravenous injection of soluble antigen. Transplantation 72: 685-693.
52. Csencsits, K., S. C. Wood, G. Lu, J. C. Magee, E. J. Eichwald, C. H. Chang, and D. K. Bishop. 2005. Graft rejection mediated by CD4+ T cells via indirect recognition of alloantigen is associated with a dominant Th2 response. Eur. J. Immunol. 35: 843-851.
53. Piccotti, J. R., S. Y. Chan, R. E. Goodman, J. Magram, E. J. Eichwald, and D. K. Bishop. 1996. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity. J. Immunol. 157: 1951-1957.
54. Groux, H., M. Bigler, J. E. de Vries, and M. G. Roncarolo. 1996. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J. Exp. Med. 184: 19-29.
55. Roncarolo, M. G., S. Gregori, B. Lucarelli, F. Ciceri, and R. Bacchetta. 2011. Clinical tolerance in allogeneic hematopoietic stem cell transplantation. Immunol. Rev. 241: 145-163.
56. Horner, B. M., M. A. Randolph, R. Duran-Struuck, E. L. Hirsh, K. K. Ferguson, A. G. Teague, P. E. Butler, and C. A. Huang. 2009. Induction of tolerance to an allogeneic skin flap transplant in a preclinical large animal model. Transplant. Proc. 41: 539-541.